Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
Faculty of Pharmacy, University of Central Punjab, Lahore, Punjab, Pakistan.
PLoS One. 2021 Nov 12;16(11):e0259766. doi: 10.1371/journal.pone.0259766. eCollection 2021.
Chronic pulmonary aspergillosis (CPA) has a wide spectrum of illnesses depending on the progression of the disease and comorbid conditions. However, there is an inadequacy of investigations regarding clinical, laboratory, risk factor and prognostic data on CPA. The current study is aimed to consider the clinical manifestations, risk factors and outcomes of CPA.
Retrospective records of all patients with a confirmed diagnosis of CPA who sought treatment at Gulab Devi Chest Hospital Lahore, Pakistan from January 2017 to December 2019 were evaluated. Data regarding demographics, clinical manifestations, comorbidities, radiographic and microbiological findings, length of hospital stay (LOS) and intensive care unit (ICU) admission was collected and analyzed to identify the factors associated with mortality. The independent factors associated with mortality were also identified by appropriate analyses.
A total of 218 CPA patients were included in this study. The mean age was 45.75 ± 6.26 years. Of these, 160 (73.4%) were male, and 65 (29.8%) had diabetes. The mean LOS was 18.5 ± 10.9 days. The most common type of CPA was simple aspergilloma (56%) followed by chronic cavitary pulmonary aspergillosis (CCPA) (31.2%). About one half of the patients had a history of pulmonary tuberculosis (TB) and treatment response rates were low in patients with active TB. The overall mortality rate was 27.1%. ICU admission was required for 78 (35.8%) patients. Diabetes mellitus (DM), hematological malignancies and chronic kidney disease (CKD) were the common underlying conditions predicting a poor outcome. Mean LOS, hematological malignancies, consolidation and ICU admission were identified as the independent factors leading to mortality.
CPA had a significant association with TB in the majority of cases. Treatment response rates in cases with active TB were comparatively low. Cases with high mean LOS, hematological malignancies, consolidation, ICU admission, CKD and DM experienced poor outcomes. High mean LOS, hematological malignancies, consolidation and ICU stay were identified as independent risk factors for mortality. Future large prospective studies, involving aspergillus specific immunoglobulin G (IgG) antibody testing, are required for a better understanding of CPA in Pakistan.
慢性肺曲霉病(CPA)的疾病谱因疾病进展和合并症的不同而广泛存在。然而,对于 CPA 的临床、实验室、危险因素和预后数据的研究还不够充分。本研究旨在探讨 CPA 的临床表现、危险因素和结局。
回顾性分析了 2017 年 1 月至 2019 年 12 月在巴基斯坦拉合尔古拉卜·德维胸部医院(Gulab Devi Chest Hospital Lahore)就诊的所有确诊为 CPA 的患者的病历记录。收集并分析了人口统计学、临床表现、合并症、影像学和微生物学发现、住院时间(LOS)和重症监护病房(ICU)入住情况等数据,以确定与死亡率相关的因素。通过适当的分析,确定与死亡率相关的独立因素。
本研究共纳入 218 例 CPA 患者,平均年龄为 45.75 ± 6.26 岁,其中 160 例(73.4%)为男性,65 例(29.8%)患有糖尿病。平均 LOS 为 18.5 ± 10.9 天。最常见的 CPA 类型为单纯曲霉肿(56%),其次是慢性空洞性肺曲霉病(CCPA)(31.2%)。约一半的患者有肺结核(TB)病史,且活动性 TB 患者的治疗反应率较低。总的死亡率为 27.1%。78 例(35.8%)患者需要入住 ICU。糖尿病(DM)、血液恶性肿瘤和慢性肾脏病(CKD)是预测不良结局的常见基础疾病。平均 LOS、血液恶性肿瘤、实变和 ICU 入住被确定为导致死亡的独立因素。
CPA 与大多数情况下的 TB 密切相关,活动性 TB 患者的治疗反应率相对较低。具有较高平均 LOS、血液恶性肿瘤、实变、ICU 入住、CKD 和 DM 的患者预后较差。较高的平均 LOS、血液恶性肿瘤、实变和 ICU 入住被确定为死亡的独立危险因素。未来需要进行更大规模的前瞻性研究,包括曲霉特异性免疫球蛋白 G(IgG)抗体检测,以更好地了解巴基斯坦的 CPA。